About Wellone Pharmaceuticals Private Limited
Data last updated:
Wellone Pharmaceuticals Private Limited is a private limited company based in Mohali, Punjab, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 16 October 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U73100PB2019PTC050106. Its GSTIN is 02AACCW5257A1ZT (Himachal Pradesh). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Sushil Kumar Sachan and Rakesh Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at D103 First Floor Tower – D Gold Homes Sector – 116 Kharar Sas Nagar, Mohali, Punjab, India – 140307.
As per the financials filed for FY 2024, the company reported a revenue of ₹49.25 Lakh, a decline of 11% compared to the previous year. For the same year it recorded a net profit of ₹65,901 (net margin 1.3%) and EBITDA of ₹93,758 (EBITDA margin 1.9%). Revenue has grown at a compounded annual rate (CAGR) of 6% over three years.
For more details, the company can be reached via its website wellonepharmaceuticals.com.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social Media
- Registered AddressD103 First Floor Tower – D Gold Homes Sector – 116 Kharar Sas Nagar, Mohali, Punjab, India – 140307
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Wellone Pharmaceuticals Private Limited
The main business activity of Wellone Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Wellone Pharmaceuticals Private Limited FY 2025 filings available
Wellone Pharmaceuticals Private Limited reported revenue of ₹49.25 Lakh (down 11% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Wellone Pharmaceuticals Private Limited
Revenue fell 11% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 6%. EBITDA fell 9% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Wellone Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹93,758 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹65,901 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Wellone Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.9% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 1.3% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Wellone Pharmaceuticals are in the company report.
Financial statements from FY 2020
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Wellone Pharmaceuticals Private Limited
Wellone Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Anthova Pharmaceuticals Private Limited | ₹49.38 Lakh (FY 2022) | •••• | •••• | 135.0% | •••• | Hapur, Uttar Pradesh, India |
| Hornbill Pharmaceuticals Private Limited | ₹49.37 Lakh (FY 2025) | •••• | •••• | 833.0% | •••• | Aurangabad, Maharashtra, India |
| Fourmost Pharmaceuticals Private Limited | ₹49.36 Lakh (FY 2025) | •••• | •••• | •••• | Nagpur, Maharashtra, India | |
| Neighbour Care Pharmaceuticals Private Limited | ₹49.34 Lakh (FY 2021) | •••• | •••• | -24.0% | •••• | Delhi, India |
| Vonmark Pharmaceuticals Private Limited | ₹49.31 Lakh (FY 2024) | •••• | •••• | 18.0% | •••• | Faridabad, Haryana, India |
| Wellone Pharmaceuticals Private Limited this company | ₹49.25 Lakh (FY 2024) | •••• | •••• | -11.0% | •••• | Mohali, Punjab, India |
| Onpharno Lifesciences Private Limited | ₹49.2 Lakh (FY 2025) | •••• | •••• | -18.0% | •••• | Surat, Gujarat, India |
| Smith Life Sciences Private Limited | ₹49.14 Lakh (FY 2025) | •••• | •••• | -4.0% | •••• | Ahmedabad, Gujarat, India |
| Timetech Lifesciences Limited | ₹49.1 Lakh (FY 2022) | •••• | •••• | 6.0% | •••• | Hyderabad, Telangana, India |
| Allincare Pharmaceuticals Private Limited | ₹49.03 Lakh (FY 2023) | •••• | •••• | 357.0% | •••• | Kolkata, West Bengal, India |
| Cynergic Lifesciences Private Limited | ₹49.01 Lakh (FY 2025) | •••• | •••• | 19.0% | •••• | Thiruchirappalli, Tamil Nadu, India |
Peers are the five companies nearest above and the five nearest below Wellone Pharmaceuticals by revenue in the Pharma industry (Formulations, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Wellone Pharmaceuticals Private Limited
Wellone Pharmaceuticals has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sushil Kumar Sachan | Director | 16 Oct 2019 | 6 Years 11 Months | Current |
| Rakesh Kumar | Director | 16 Oct 2019 | 6 Years 11 Months | Current |
| Manju Devi | Director | 26 Feb 2020 | 6 Years 7 Months | Current |
Ownership and Shareholding of Wellone Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Wellone Pharmaceuticals Private Limited
Wellone Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Wellone Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Wellone Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Wellone Pharmaceuticals Private Limited
Wellone Pharmaceuticals Private Limited has 5 board changes on record since 2019: 3 appointments and 2 cessations. The latest: Gopal Verma ceased to be Director on 16 Apr 2022.
Credit Ratings, Litigation & Regulatory Alerts for Wellone Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Wellone Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Wellone Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Wellone Pharmaceuticals Private Limited
Wellone Pharmaceuticals has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 02AACCW5257A1ZT | Himachal Pradesh | Active | 06 Nov 2019 |
| 09AACCW5257A1ZF | Uttar Pradesh | Active | 17 Dec 2019 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Wellone Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Wellone Pharmaceuticals Private Limited
Wellone Pharmaceuticals is an active private limited company based in Mohali, Punjab, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 16 October 2019 (7+ years old) and is registered under CIN U73100PB2019PTC050106.
Wellone Pharmaceuticals reported revenue of ₹49.25 Lakh for FY 2024 (down 11% YoY).
Wellone Pharmaceuticals has 3 current directors:
- Sushil Kumar Sachan - Director
- Rakesh Kumar - Director
- Manju Devi - Director
Wellone Pharmaceuticals reported a net profit of ₹65,901 (net margin 1.3%) and EBITDA of ₹93,758 (EBITDA margin 1.9%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Wellone Pharmaceuticals is 6% over three years. In the latest year (FY 2024) revenue fell 11%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Wellone Pharmaceuticals is 02AACCW5257A1ZT, registered in Himachal Pradesh. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 09AACCW5257A1ZF (Uttar Pradesh).
The CIN (Corporate Identification Number) of Wellone Pharmaceuticals is U73100PB2019PTC050106. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Wellone Pharmaceuticals was incorporated on 16 October 2019, making it 7+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of Wellone Pharmaceuticals by revenue are Anthova Pharmaceuticals Private Limited, Hornbill Pharmaceuticals Private Limited, Fourmost Pharmaceuticals Private Limited, Neighbour Care Pharmaceuticals Private Limited, Vonmark Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Formulations, Pharmaceuticals).
Gopal Verma ceased to be Director on 16 Apr 2022. Manju Devi ceased to be Additional Director on 31 Dec 2020. Manju Devi was appointed as Director on 26 Feb 2020. Wellone Pharmaceuticals has 5 board changes on record in total.
Wellone Pharmaceuticals can be reached through the website wellonepharmaceuticals.com. Its registered office is in Mohali, Punjab, India.